In GPER- and ERα-positive ovarian cancer cells, EGFR/ERK signaling is activated by 17β-estradiol and the selective GPER ligand G1, respectively; in contrast, however, the progesterone receptor only responds to E2 [11]. Here, ESR1 is linked to ovarian carcinoma.